Skip to main content

Table 1 The relationship between CD90 expression and clinical parameters in human HCC (n = 66)

From: miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma

Parameters CD90Low CD90High p Value
Male/Female   34/4 26/2 0.969
Age*   52 (32-75) 45.5 (32-60) 0.524
HBsAg     
  Positive 34 (89.5 %) 25 (89.3 %) 1.000
  Negative 4 (10.5 %) 3 (10.7 %)
AFP     
  Normal 14 (36.8 %) 12 (42.9 %) 0.629
  High 24 (63.2 %) 16 (57.1 %)
Vascular Invasion     
  Positive 2 (5.3 %) 9 (32.1 %) 0.010
  Negative 36 (94.7 %) 19 (67.9 %)
Tumer Size(cm)*   4.75 (2-18) 6.5 (3-16) 0.077
Recurrence   21 (55.3 %) 24 (85.7 %) 0.009
Edmondson Grade I/II 25 (65.8 %) 15 (53.6 %) 0.315
  III/IV 13 (34.2 %) 13 (46.4 %)
  1. *Value expressed in the midian with the range in parentheses